ContextPrescription drugs are instrumental to managing and preventing chronic disease.
Recent changes in US prescription drug cost sharing could affect access to them …

Digestion assays with simulated gastric fluid have been introduced for characterization of
food proteins to imitate the effect of stomach proteolysis on dietary compounds in vitro. By …

As pharmaceutical expenditure continues to rise, third-party payers in most high-income
countries have increasingly shifted the burden of payment for prescription drugs to patients …

Background Pharmaceuticals are important interventions that could improve people's health.
Pharmaceutical pricing and purchasing policies are used as cost‐containment measures to …

States are reacting to increased Medicaid drug costs by implementing cost-control policies,
such as preferred drug lists (PDLs) and prior authorization. PDLs have risks as well as …

Background—As medication spending grows, Medicare Part D will need to adapt its
coverage policies according to emerging evidence from a variety of insurance policies. We …

This work aims to provide a systematic and updated survey of original scientific studies on
the effect of the introduction of reference pricing (RP) policies in Organisation for Economic …

Background Public policy makers and benefit plan managers need to restrain rising
pharmaceutical drug costs while preserving access and optimizing health benefits …

BACKGROUND:: Evaluations of drug cost-sharing policies within the same population are
needed for a fair comparison of different options. OBJECTIVE:: The aim of this work was to …

This paper describes and assesses pharmaceutical pricing and reimbursement policies in
Canada, considering them in the context of the broader policy and market environment in …